World's Best Scientists 2026 revealed!
Jan Gerstoft

Jan Gerstoft

Award Badge
Immunology
Denmark
2026

D-Index & Metrics

Immunology

D-Index
86
Citations
28518
World Ranking
1257
National Ranking
10

Medicine

D-Index
86
Citations
28518
World Ranking
14084
National Ranking
154

Research.com Recognitions

  • 2026 - Research.com Immunology in Denmark Leader Award

Overview

Jan Gerstoft is affiliated with Rigshospitalet in Denmark and focuses their research primarily in the field of Medicine, with particular emphasis on Infectious Diseases, Emergency Medicine, and Epidemiology. Their academic output includes contributions to subfields such as Virology and Surgery.

The scientist's research centers mainly on HIV-related health complications and treatments, encompassing investigations into HIV/AIDS research and interventions, drug development and treatment specific to HIV/AIDS, as well as broader HIV research and treatment topics. Additional topics covered include Hepatitis C virus research, liver disease diagnosis and treatment, and Hepatitis B virus studies.

Gerstoft has published extensively in several key medical and infectious disease journals. The most frequent venues for their publications include:

  • AIDS
  • Frontiers in Immunology
  • HIV Medicine
  • Open Forum Infectious Diseases
  • The Lancet HIV

Among recent papers authored or coauthored by Jan Gerstoft are:

  • Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021), published in The Lancet HIV
  • Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial (2023), published in Nature Medicine
  • Humoral response to two doses of BNT162b2 vaccination in people with HIV (2021), published in Journal of Internal Medicine
  • HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort study (2021), published in European Heart Journal
  • Impact of Age and HIV Status on Immune Activation, Senescence and Apoptosis (2020), published in Frontiers in Immunology

Frequent collaborators with whom Jan Gerstoft has worked include:

  • Susanne Dam Nielsen
  • Thomas Benfield
  • Gitte Kronborg
  • Işık Somuncu Johansen
  • Andreas Dehlbæk Knudsen

Best Publications

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Survival of Persons with and without HIV Infection in Denmark, 1995–2005

    Nicolai Lohse;Ann-Brit Eg Hansen;Gitte Pedersen;Gitte Kronborg

  • A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus

    Thomas N. Kledal;Mette M. Rosenkilde;Florence Coulin;Graham Simmons

  • Mortality Attributable to Smoking Among HIV-1–Infected Individuals: A Nationwide, Population-Based Cohort Study

    Marie Helleberg;Shoaib Afzal;Gitte Kronborg;Carsten Schade Larsen

  • Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin

    Peter Garred;Hans O Madsen;Ulla Balslev;Bo Hofmann

  • Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study

    Hans-Jürgen Stellbrink;Chloe Orkin;Jose Ramon Arribas;Juliet Compston

  • Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study

    Niels Obel;Henrik F. Thomsen;Gitte Kronborg;Carsten S. Larsen

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

    Mark Sulkowski;Christophe Hezode;Jan Gerstoft;John M Vierling

  • Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.

    Edwin DeJesus;Gisela Herrera;Eugenio Teofilo;Jan Gerstoft

  • Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    Homie Razavi;Sarah Robbins;Stefan Zeuzem;Francesco Negro

  • Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

    Frederik Neess Engsig;Ann-Brit Eg Hansen;Lars Haukali Omland;Gitte Kronborg

  • Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

    Jesper Eugen-Olsen;Astrid K.N. Iversen;Peter Garred;Uffe Koppelhus

  • Clinical course of primary HIV infection: consequences for subsequent course of infection.

    C. Pedersen;B. O. Lindhardt;B. L. Jensen;E. Lauritzen

  • Strategies to manage hepatitis C virus (HCV) disease burden

    H Wedemeyer;A S Duberg;M Buti;W M Rosenberg

  • Syphilis and human immunodeficiency virus (HIV)-1 coinfection: influence on CD4 T-cell count, HIV-1 viral load, and treatment response.

    Kristian Kofoed;Jan Gerstoft;Lars R Mathiesen;Thomas Benfield

  • Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study

    Line D Rasmussen;Margaret T May;Gitte Kronborg;Carsten S Larsen

  • Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

    C Pedersen;C M Nielsen;B F Vestergaard;J Gerstoft

Frequent Co-Authors

Court Pedersen
Court Pedersen Odense University Hospital
Henrik Ullum
Henrik Ullum Statens Serum Institut
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Thomas Benfield
Thomas Benfield Copenhagen University Hospital
Bente Klarlund Pedersen
Bente Klarlund Pedersen University of Copenhagen
Peter Skinhøj
Peter Skinhøj Copenhagen University Hospital
Henrik Toft Sørensen
Henrik Toft Sørensen Aarhus University
Lars Mathiesen
Lars Mathiesen Hvidovre Hospital
Andreas Kjaer
Andreas Kjaer University of Copenhagen
Børge G. Nordestgaard
Børge G. Nordestgaard University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but looking to broaden their career options in healthcare, several online degree pathways offer flexible and accessible entry points. Many programs cater to individuals transitioning into nursing, such as the best online rn programs for non nurses, which provide comprehensive training without the need for prior nursing experience.

Accelerated options are popular for students seeking faster routes to licensure. Exploring the easiest absn program to get into can help prospective nurses find flexible curricula designed to fit busy schedules and varied backgrounds.

For those aiming at practical nursing roles, fastest and easiest lpn programs offer efficient pathways to begin clinical work in a shorter timeframe, often with online or hybrid formats.

Advancing nursing careers to higher practice levels is also feasible through online education. Investigating what is the easiest np program reveals programs designed for smoother admissions and accelerated study, paving the way for specialized roles that intersect with immunological sciences.

Best Scientists Citing Jan Gerstoft

Trending Scientists

Recently Published Articles